19 October 2026 AMERICAN TUNGSTEN & ANTIMONY LTD ACN 168 269 752 A 15B/531 Hay Street, Subiaco WA 6008 Australia P +61 (08) 6256 4403 | E [email protected] | W www.ataa.com Page 1 of 3 AT4 APPOINTS US DEFENCE SUPPLY CHAIN AND CRITICAL MINERALS EXECUTIVE TO BOARD Dr Ivy Estabrooke brings US...
Dr Ivy Estabrooke Appointed Director and Appendix 3X
Filed with ASX · · 5 pages · English
Summary by 6ix AI
American Tungsten & Antimony Ltd has announced the appointment of Dr Ivy Estabrooke as an Independent Non-Executive Director, effective immediately. Dr Estabrooke brings extensive experience in US Government procurement and critical minerals, which will enhance the company's capabilities in these areas. The filing includes an Initial Director’s Interest Notice detailing Dr Estabrooke's interests in the company, confirming her independence as a director. This strategic appointment is seen as crucial for advancing the company's US-focused mine-to-metal strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
American Tungsten & Antimony Ltd on 6ix
Story so far
Earlier from American Tungsten & Antimony
- Becoming a substantial holder for EUZ
- Antimony and Silver Results Support Mine-to-Metal Strategy
- Regulus II Antimony Grade Exceeded at Del Sol
- Change of Company Address
- Annual Report to shareholders
Later from American Tungsten & Antimony
- Trading Halt
- Suspension from Quotation
- AT4 Completes Acquisition of Del Sol Refinery
- Reinstatement to Quotation
- Notice of AGM/Proxy Form/Shareholder Letter
Follow American Tungsten & Antimony into a list and get an email when it puts out news.
Follow American Tungsten & Antimony